Similarly, CYP4B1 could also be detected in breast and tumor breast tissues, with 76.9% or 84.6%, respectively [113], thus suggesting an increased risk of developing prostate or breast cancer with increased CYP4B1 expression. This evidence concerns the gene CYP4B1 and breast carcinoma.